Laurence A Roth

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Biodegradable Polymers. Top assignees: Focal, Inc., C. R. Bard, Inc., Pykus Therapeutics, Inc.. Active years: 1989-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence A Roth. Retrieved from https://idiyas.com/inventor/laurence-a-roth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 87.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 11

Forward Citations = 1,526(Granted Patents)

Location History:

Hudson, NH (US) (1989)
Londonderry, NH (US) (1989)
Cambridge, MA (US) (2014 - 2017)
Windham, NH (US) (1997 - 2024)

Company Filing History:

Pykus Therapeutics, Inc.

patents

4. 2 out of 11

Semprus Biosciences Corporation

patents

5. 1 out of 91

Arrow International Limited

Navigation Sciences, Inc.

patents

Years Active: 1989-2026

Loading Chart...

Areas of Expertise:

Biodegradable Polymers

Hydrogel Formulations

Non-Fouling Surfaces

Dialysis Catheters

Photothermoforming

Intraluminal Gels

Targeted Delivery

Laser Catheter

Controlled Removal

Surface Modification

Medical Devices

Sensor Deployment

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12708332 - SYSTEM AND METHOD FOR PERCUTANEOUS DEPLOYMENT OF SENSORS (2026-08-18),

2. 12233157 - Hydrogel formulations and methods and devices for administration of the same (2025-02-25),

3. 11883378 - Hydrogel formulations and methods and devices for focal administration of the same (2024-01-30),

4. 9795762 - Surface modification for dialysis catheters (2017-10-24),

5. 9764069 - Articles having non-fouling surfaces and processes for preparing the same including pretreatment of articles (2017-09-19),

6. 8632838 - Articles having non-fouling surfaces and processes for preparing the same including pretreatment of articles (2014-01-21),

7. 6911216 - Targeted delivery via biodegradable polymers (2005-06-28),

8. 6176871 - Apparatus and methods for intraluminal photothermoforming (2001-01-23),

9. 5879713 - Targeted delivery via biodegradable polymers (1999-03-09),

10. 5849035 - Methods for intraluminal photothermoforming (1998-12-15),

11. 5779673 - Devices and methods for application of intraluminal photopolymerized gels (1998-07-14),

12. 5741323 - Polymeric article for intraluminal photothermoforming (1998-04-21),

13. 5665063 - Methods for application of intraluminal photopolymerized gels (1997-09-09),

14. 5662712 - Apparatus for intraluminal photothermoforming (1997-09-02),

15. 4850351 - Wire guided laser catheter (1989-07-25),

Title: Innovator in Ocular Hydrogel Technologies: Laurence A. Roth

Introduction

Laurence A. Roth, an accomplished inventor based in Windham, NH, holds a remarkable portfolio of 15 patents. His innovative contributions primarily focus on hydrogel formulations that have the potential to revolutionize the treatment of ocular disorders.

Latest Patents

Roth's recent advancements include the development of hydrogel formulations and methods for their administration, specifically aimed at addressing various ocular disorders. One notable invention provides methods and polymer compositions for creating a hydrogel within the eye of a subject using a biocompatible polymer. This hydrogel is synthesized from a nucleo-functional polymer, such as thiolated hyaluronic acid, which contains multiple thio-functional groups. Additionally, the invention incorporates an electro-functional polymer, like a poly(ethylene glycol), that features thiol-reactive groups.

Another significant patent describes formulations and methods for the focal administration of the hydrogel. This invention similarly consists of a nucleo-functional polymer modified with hydroxyl and thio-functional groups and an electro-functional polymer that is biocompatible. These hydrogel formulations are designed to be effective in treating a range of disorders, including conditions affecting the eye. The targeted administration methods and devices described are noteworthy for their potential to enhance therapeutic outcomes.

Career Highlights

Throughout his career, Laurence A. Roth has collaborated with prominent companies in the medical field, including Focal, Inc. and C.R. Bard, Inc. His work has significantly advanced the understanding and application of hydrogel technologies in clinical settings.

Collaborations

Roth has worked alongside notable colleagues, including Stephen Jack Herman and Patrick K. Campbell. Their collaborative efforts have contributed to the innovative solutions that Roth is known for within the medical and scientific communities.

Conclusion

With a track record of impactful patents and significant collaborations in the field of ocular treatments, Laurence A. Roth continues to establish himself as a leading inventor. His work on hydrogel formulations not only highlights his expertise but also reflects his commitment to enhancing patient care through innovative medical solutions.

Profile summary based on public USPTO records.